Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)

Kim Hwi Seung ,  이우제

Diabetes and Metabolism Journal

2022 .07

Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study

김휘승 ,  윤태관 ,  정창희 외 2명

Diabetes and Metabolism Journal

2022 .07

Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43: 158-73)

이지연 ,  강은석

Diabetes and Metabolism Journal

2019 .01

Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2015;39:342-7)

Ken-ichi Aiha ,  a ,  Masataka Sata

Diabetes and Metabolism Journal

2015 .01

Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea (Diabetes Metab J 2016;40:482-93)

윤재승 ,  고승현

Diabetes and Metabolism Journal

2017 .01

Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea (Diabetes Metab J 2016;40:482-93)

김남훈

Diabetes and Metabolism Journal

2017 .01

New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors

정찬희

Endocrinology and Metabolism

2021 .01

Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition (Diabetes Metab J 2023;47:784-95)

배재현

Diabetes and Metabolism Journal

2024 .01

Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition (Diabetes Metab J 2023;47:784-95)

이호균 ,  정일 ,  박병서 외 9명

Diabetes and Metabolism Journal

2024 .01

새로운 당뇨병 치료제

김두만

대한의사협회지

2017 .01

Early Assessment of the Risk for Gestational Diabetes Mellitus: Can Fasting Parameters of Glucose Metabolism Contribute to Risk Prediction? (Diabetes Metab J 2019;43:785-93)

Ch ,  istian S. Göbl ,  And 외 2명

Diabetes and Metabolism Journal

2020 .01

Early Assessment of the Risk for Gestational Diabetes Mellitus: Can Fasting Parameters of Glucose Metabolism Contribute to Risk Prediction? (Diabetes Metab J 2019;43:785-93)

양예슬 ,  정혜승

Diabetes and Metabolism Journal

2020 .01

Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data (Diabetes Metab J 2017;41:393-404)

이상열 ,  우정택

Diabetes and Metabolism Journal

2017 .01

Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data (Diabetes Metab J 2017;41:393-404)

윤재승

Diabetes and Metabolism Journal

2017 .01

The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes

김광실 ,  박중현 ,  원종철

Endocrinology and Metabolism

2019 .01

Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis (Diabetes Metab J 2022;46:781-802)

Tianqi Zhang ,  Ma ,  nie Shaw 외 2명

Diabetes and Metabolism Journal

2022 .09

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)

Gunt ,  am Sche ,  nthane

Diabetes and Metabolism Journal

2021 .01

Clinical Characteristics of Diabetes in People with Mitochondrial DNA 3243A>G Mutation in Korea (Diabetes Metab J 2024;48:482-6)

노은후 ,  곽수헌

Diabetes and Metabolism Journal

2024 .07

The Necessity of the Simple Tests for Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus Patients without Neuropathic Symptoms in Clinical Practice (Diabetes Metab J 2018;42:442-6)

박정환 ,  김동선

Diabetes and Metabolism Journal

2018 .01